首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Profiles of drug substances, excipients and related methodology

缩写:

ISSN:1871-5125

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引190
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yahya M Alshehri,Abdulrahman A Al-Majed,Mohamed W Attwa et al. Yahya M Alshehri et al.
Lodenafil is a class of drugs called an inhibitor of PDE5 which also include a wide range of other erectile medicines, such as sildenafil, tadalafil and vardenafil. It is part of a new generation of PDE5 inhibitors that includes udenafil an...
Nasr Y Khalil,Ahmed H Bakheit,Hamad M Alkahtani et al. Nasr Y Khalil et al.
Vinpocetine (VIN) is a herbal supplement extracted from the periwinkle plant. It is a multi-action agent, which is used to treat various neurological disorders such as Alzheimer's and Parkinson's disease. Vinpocetine has also anti-inflammat...
Majed J Al-Wadei,Ahmed H Bakheit,Alaa A-M Abdel-Aziz et al. Majed J Al-Wadei et al.
Betaxolol is a relatively cardioselective β-adrenoceptor blocking drug, with no partial agonist (intrinsic sympathomimetic) activity and weak membrane-stabilizing (local anesthetic) activity. Betaxolol selectively and competitively binds t...
Ahmed H Bakheit,Raisuddin Ali,Ali D Alshahrani et al. Ahmed H Bakheit et al.
The present study describes a comprehensive profile of Bisoprolol including detailed nomenclature; formulae, elemental analysis, appearance, its uses, applications, and methods for the preparation are outlined. The profile contains physicoc...
Gunawan Indrayanto,Galih Satrio Putra,Farida Suhud Gunawan Indrayanto
This present review described the validation method of in-vitro bioassay for its application in herbal drug research. Seven sequencing steps that can be taken for performing a valid bioassay include: literature survey, sample stability eval...
Ibrahim A Darwish,Hany W Darwish,Ahmed H Bakheit et al. Ibrahim A Darwish et al.
Irbesartan, (2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one), is a member of non-peptide angiotensin II receptor antagonists used worldwide in the treatment of hypertension and diabetic ne...
Ahmed H Bakheit,Hamad M Al-Kahtani,Salem Albraiki Ahmed H Bakheit
Rabeprazole belongs to the class of anti-secretory drugs, with benzimidazoles substitution. These drugs induce gastric acid secretion through precise inhibition of the enzyme H+/K+-ATPase (acid or proton pump). This effect helps to treat an...
Ibrahim A Darwish,Abdulrahman A Al-Majed,Nawaf A Alsaif et al. Ibrahim A Darwish et al.
Darunavir: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl] (isobutyl)amino}-3-hydroxy-1-phenyl-2-butanyl]carbamate is a synthetic non-peptide protease inhibitor. On June 2006, it was first approved by the F...
Ahmed A Abdelgalil,Hamad M Al-Kahtani,Fahad I Al-Jenoobi Ahmed A Abdelgalil
Erlotinib (OSI-774), marketed by Genentech as Tarceva®, is anticancer drug approved by US-FDA for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Pancreatic Cancer. Erlotinib inhibited epidermal growth factor receptor (EGFR) that b...